Trade Summary

Yesterday, Chen Bihua, serving as Dir at BlossomHill Therapeutics, Inc. (BLSM), purchased 312,500 shares at $16.00 per share, for a total transaction value of $5,000,000.00. Following this transaction, Chen Bihua now holds 3,614,034 shares of BLSM.

This purchase represents a 9.47% increase in Chen Bihua's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Monday, August 10, 2026 and publicly disclosed via SEC Form 4 filing on Monday, August 10, 2026 at 6:32 PM ET, meaning the disclosure happened on the same day as the trade.

BlossomHill Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.